ANTENATAL PREVENTION OF NEONATAL RESPIRATORY DISTRESS SYNDROME


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The paper describes approaches to the antenatal prevention of neonatal respiratory distress syndrome. It analyzes the feasibility of using antenatal corticosteroid therapy in different pregnancy periods and discusses the efficiency of repeated courses of drugs and the expediency of their administration. Methods to estimate fetal lung maturity are presented.

Texto integral

Acesso é fechado

Sobre autores

S. PAVLOVICH

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia; I.M. Sechenov First Moscow State Medical University

Email: s_pavlovich@oparina4.ru

Bibliografia

  1. Пренатальный аудит при преждевременных родах / Кулаков В.И., Вихляева Е.М., Байбарина Е.Н. и др. — М.-Эдинбург, 2005.
  2. ACOG Committee Opinion, N 273. Antenatal Corticosteroid therapy for fetal maturation // Obstet. and Gynecol. — 2002. — Vol. 99. — P. 871—873.
  3. ACOG Committee Opinion, N 80. Premature rupture of membranes // Obstet. and Gynecol. — 2007. — Vol. 109. — P. 1007—1019.
  4. Ballard P.L., Ballard R.A. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids // Am. J. Obstet. Gynecol. — 1995. — Vol. 173. — P. 254—262.
  5. Baud O., Foix-L’Helias L., Kaminski M. et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants // N. Engl. J. Med. — 1999. — Vol. 341. — P. 1190—1196.
  6. Brownfoot F.C., Crowther C.A., Middleton P. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth // Cochrane Database Syst. Rev. — 2008. — Issue 4. — Art. CD00 6764. doi: 10.1002/14651858.CD006764.pub2.
  7. Crowther C.A., Harding J.E. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease // Cochrane Database Syst. Rev. — 2007. — Issue 4. — Art. CD003935. doi: 10.1002/14651858.CD003935.pub2.
  8. Dalziel S.R., Lim V.K., Lambert A. et al. Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial // Br. Med. J. — 2005. — Vol. 331. — P. 665— 668.
  9. Egerman R.S., Mercer B.M., Doss J.L., Sibai B.M. A randomized, controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome // Am. J. Obstet. Gynecol. — 1998. — Vol. 179. — P. 1120—1123.
  10. Elimian A., Figueroa R., Spitzer A.R. et al. Antenatal corticosteroids: are incomplete courses beneficial? // Obstet. and Gynecol. — 2003. — Vol. 102. — P. 352—355.
  11. Elimian A., Garry D., Figueroa R. et al. Antenatal betamethasone compared with dexamethasone (betacode trial): a randomized controlled trial // Obstet. and Gynecol. — 2007 — Vol. 110. — P. 26-30.
  12. Grenache D.G., Gronowski A.M. Fetal lung maturity // Clin. Biochem. — 2006. — Vol. 39. — P. 1—10.
  13. Liggins G.C., Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants // Pediatrics. — 1972. — Vol. 50. — P. 515—525.
  14. Moss T.J.M., Sloboda D.M. Programming effects of excess glucocorticoid exposure in late gestation // Advances in Experimental Medicine and Biology. — 2006. — Vol. 57. — P. 177—186.
  15. National Institutes of Health Consensus Development Conference Statement. Effect of corticosteroids for fetal maturation on perinatal outcomes. Feb. 28 - Mar. 2 1994 // Am J. Obstet. Gynecol. — 1995. — Vol. 173. — P. 246—252.
  16. National Institutes of Health. Antenatal corticosteroids revisited: Repeat courses // NIH. Consensus Statement. — 2000. — Vol. 17. — P. 1—18.
  17. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth // Cochrane Database Syst. Rev. — 2006. — Issue 3. — Art. CD004454. doi: 10.1002/14651858. CD004454.pub2.
  18. Rollins G. New paradigms in fetal lung maturity testing. What are the options for labs? // Clin. Lab. News. — 2009. — Vol. 35. — P. 1—7.
  19. Senat M.V., Minoui S., Multon O. et al. Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labour: a randomised study // Br. J. Obstet. Gynaecol. — 1998. — Vol. 105. — P. 749—755.
  20. Stutchfield P., Whitaker R., Russell I. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial // Br. Med. J. — 2005. — Vol. 331. — P. 662—664.
  21. Vermillion S.T., Soper D.E., Newman R.B. Neonatal sepsis and death after multiple courses of antenatal betamethasone therapy // Am. J. Obstet. Gynecol. — 2000. — Vol. 183. — P. 810—814.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2011

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies